OncoTrackTM - Validation of NGS based Liquid Biopsy Assay for Monitoring Cancer Treatment
Vidya H Veldore,
Principal Scientist ,
MedGenome Labs Pvt Ltd
This presentation will focus on validation of plasma circulating tumor DNA as biomarker for genomic testing in NSCLC patients: MedGenome in collaboration with India's Premeir Cancer Hospital. Key aspects of validation of a clinical diagnostic assay that includes concordance assessment between tissue biopsy and plasma CtDNA for biomarker status, specificity, sensitivity and diagnostic accuracy of the testing will be discussed.
|
|
